Evolent Health (EVH) Tops Q1 EPS by 3c

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $49.45 million versus the consensus estimate of $47.4 million.

GUIDANCE:

Evolent Health sees Q2 2016 revenue of $51-52 million.

Evolent Health sees FY2016 revenue of $212-220 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Evolent Health (EVH) PT Raised to $6 at TD Cowen
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)